Bioadaptives Stock Buy Hold or Sell Recommendation
| BDPT Stock | USD 0.10 0.01 9.09% |
Given the investment horizon of 90 days and your bold attitude towards risk, our recommendation regarding BioAdaptives is 'Cautious Hold'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell BioAdaptives given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for BioAdaptives, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out BioAdaptives Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as BioAdaptives and provide practical buy, sell, or hold advice based on investors' constraints. BioAdaptives. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
BioAdaptives |
Execute BioAdaptives Buy or Sell Advice
The BioAdaptives recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on BioAdaptives. Macroaxis does not own or have any residual interests in BioAdaptives or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute BioAdaptives' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Good | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
BioAdaptives Trading Alerts and Improvement Suggestions
| BioAdaptives is way too risky over 90 days horizon | |
| BioAdaptives has some characteristics of a very speculative penny stock | |
| BioAdaptives appears to be risky and price may revert if volatility continues | |
| BioAdaptives has high likelihood to experience some financial distress in the next 2 years | |
| BioAdaptives currently holds 450.26 K in liabilities. BioAdaptives has a current ratio of 0.04, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist BioAdaptives until it has trouble settling it off, either with new capital or with free cash flow. So, BioAdaptives' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like BioAdaptives sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for BioAdaptives to invest in growth at high rates of return. When we think about BioAdaptives' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 19.78 K. Net Loss for the year was (1.05 M) with profit before overhead, payroll, taxes, and interest of 10.11 K. | |
| BioAdaptives currently holds about 49.58 K in cash with (158.65 K) of positive cash flow from operations. |
BioAdaptives Returns Distribution Density
The distribution of BioAdaptives' historical returns is an attempt to chart the uncertainty of BioAdaptives' future price movements. The chart of the probability distribution of BioAdaptives daily returns describes the distribution of returns around its average expected value. We use BioAdaptives price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of BioAdaptives returns is essential to provide solid investment advice for BioAdaptives.
| Mean Return | 6.53 | Value At Risk | -35.82 | Potential Upside | 83.33 | Standard Deviation | 41.21 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of BioAdaptives historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
BioAdaptives Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to BioAdaptives or Consumer Defensive sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that BioAdaptives' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a BioAdaptives pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 5.94 | |
β | Beta against Dow Jones | 8.48 | |
σ | Overall volatility | 41.21 | |
Ir | Information ratio | 0.16 |
BioAdaptives Volatility Alert
BioAdaptives is showing large volatility of returns over the selected time horizon. BioAdaptives is a potential penny stock. Although BioAdaptives may be in fact a good instrument to invest, many penny pink sheets are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in BioAdaptives. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on BioAdaptives instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.BioAdaptives Fundamentals Vs Peers
Comparing BioAdaptives' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze BioAdaptives' direct or indirect competition across all of the common fundamentals between BioAdaptives and the related equities. This way, we can detect undervalued stocks with similar characteristics as BioAdaptives or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of BioAdaptives' fundamental indicators could also be used in its relative valuation, which is a method of valuing BioAdaptives by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare BioAdaptives to competition |
| Fundamentals | BioAdaptives | Peer Average |
| Return On Asset | -3.43 | -0.14 |
| Operating Margin | (33.58) % | (5.51) % |
| Current Valuation | 544.74 K | 16.62 B |
| Shares Outstanding | 160.49 M | 571.82 M |
| Shares Owned By Insiders | 7.39 % | 10.09 % |
| Price To Earning | (14.28) X | 28.72 X |
| Price To Sales | 7.53 X | 11.42 X |
| Revenue | 19.78 K | 9.43 B |
| Gross Profit | 10.11 K | 27.38 B |
| EBITDA | (643.76 K) | 3.9 B |
| Net Income | (1.05 M) | 570.98 M |
| Cash And Equivalents | 49.58 K | 2.7 B |
| Total Debt | 450.26 K | 5.32 B |
| Current Ratio | 0.04 X | 2.16 X |
| Book Value Per Share | (0.01) X | 1.93 K |
| Cash Flow From Operations | (158.65 K) | 971.22 M |
| Earnings Per Share | (0.02) X | 3.12 X |
| Number Of Employees | 3 | 18.84 K |
| Beta | -0.29 | -0.15 |
| Market Capitalization | 144.44 K | 19.03 B |
| Total Asset | 148.59 K | 29.47 B |
| Retained Earnings | (2.96 M) | 9.33 B |
| Working Capital | (160 K) | 1.48 B |
| Current Asset | 156 K | 9.34 B |
| Current Liabilities | 316 K | 7.9 B |
| Z Score | -41.0 | 8.72 |
| Net Asset | 148.59 K |
BioAdaptives Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as BioAdaptives . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About BioAdaptives Buy or Sell Advice
When is the right time to buy or sell BioAdaptives? Buying financial instruments such as BioAdaptives Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having BioAdaptives in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Corona Opportunity Thematic Idea Now
Corona Opportunity
Firms that are involved in some capacity in making products or providing services to the public to buttle the virus directly or indirectly. This also includes some defencive and contrarian stocks and ETFs that are managing to avoid the big market correction coused by coronavirus. The Corona Opportunity theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Corona Opportunity Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for BioAdaptives Pink Sheet Analysis
When running BioAdaptives' price analysis, check to measure BioAdaptives' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAdaptives is operating at the current time. Most of BioAdaptives' value examination focuses on studying past and present price action to predict the probability of BioAdaptives' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAdaptives' price. Additionally, you may evaluate how the addition of BioAdaptives to your portfolios can decrease your overall portfolio volatility.